These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18574553)

  • 1. Pharmacokinetics of olmesartan medoxomil in hemodialysis patients: little effect of dialysis upon its pharmacokinetics.
    Tanaka H; Nagasawa Y; Matsui I; Hamano T; Iwatani H; Kawada N; Horio M; Ito T; Isaka Y; Imai E
    Clin Exp Nephrol; 2009 Feb; 13(1):61-5. PubMed ID: 18574553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of olmesartan medoxomil in pediatric patients with hypertension.
    Wells TG; Blowey DL; Sullivan JE; Blumer J; Sherbotie JR; Song S; Rohatagi S; Heyrman R; Salazar DE
    Paediatr Drugs; 2012 Dec; 14(6):401-9. PubMed ID: 22880942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of olmesartan medoxomil plus hydrochlorothiazide combination in healthy subjects.
    Kreutz R; Bolbrinker J; Huber M
    Clin Drug Investig; 2006; 26(1):29-34. PubMed ID: 17163232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic profiles of a fixed-dose combination of olmesartan medoxomil and amlodipine in healthy Chinese males and females.
    Chen X; Hu P; Jiang J; Liu T; Zhong W; Liu H; Zhao Q
    Clin Drug Investig; 2012 Dec; 32(12):783-90. PubMed ID: 23160920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and safety profile of olmesartan medoxomil in healthy Chinese subjects after single and multiple administrations.
    Jiang J; Liu D; Hu P
    Pharmazie; 2009 May; 64(5):323-6. PubMed ID: 19530443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacodynamics of olmesartan and azelnidipine in patients with hypertension: a population pharmacokinetic/pharmacodynamic analysis.
    Tanigawara Y; Yoshihara K; Kuramoto K; Arakawa K
    Drug Metab Pharmacokinet; 2009; 24(4):376-88. PubMed ID: 19745564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of olmesartan following oral administration of its prodrug, olmesartan medoxomil: in healthy volunteers and hypertensive patients.
    Yoshihara K; Gao Y; Shiga H; Wada DR; Hisaoka M
    Clin Pharmacokinet; 2005; 44(12):1329-42. PubMed ID: 16372830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of olmesartan hexetil: a new potential prodrug of olmesartan.
    El-Gamal MI; Anbar HS; Chung HJ; Kim HI; Cho YJ; Lee BS; Lee SA; Moon JY; Lee DJ; Kwon D; Choi WJ; Jeon HR; Oh CH
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1347-50. PubMed ID: 23347686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olmesartan medoxomil treatment is associated with decreased plasma B-type natriuretic peptide levels in patients on hemodialysis.
    Suzuki R; Honda H; Niikura K; Akizawa T
    Clin Exp Hypertens; 2012; 34(2):125-31. PubMed ID: 21967019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olmesartan medoxomil: influence of age, renal and hepatic function on the pharmacokinetics of olmesartan medoxomil.
    von Bergmann K; Laeis P; Püchler K; Sudhop T; Schwocho LR; Gonzalez L
    J Hypertens Suppl; 2001 Jun; 19(1):S33-40. PubMed ID: 11451213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of colesevelam HCl on the single-dose pharmacokinetics of glimepiride, extended-release glipizide, and olmesartan medoxomil.
    He L; Wickremasingha P; Lee J; Tao B; Mendell-Harary J; Walker J; Wight D
    J Clin Pharmacol; 2014 Jan; 54(1):61-9. PubMed ID: 24019110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of amlodipine and olmesartan after administration of amlodipine besylate and olmesartan medoxomil in separate dosage forms and as a fixed-dose combination.
    Rohatagi S; Lee J; Shenouda M; Haworth S; Bathala MS; Allison M; Rubets I; Heyrman R; Noveck R; Salazar DE
    J Clin Pharmacol; 2008 Nov; 48(11):1309-22. PubMed ID: 18974285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients.
    Honda H; Hosaka N; Aoshima Y; Hirai Y; Michihata T; Akizawa T
    Clin Exp Hypertens; 2012; 34(1):17-23. PubMed ID: 22149003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetic Modeling of Olmesartan, the Active Metabolite of Olmesartan Medoxomil, in Patients with Hypertension.
    Kodati D; Kotakonda HK; Yellu N
    Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):573-581. PubMed ID: 27535556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olmesartan medoxomil: a review of its use in the management of hypertension.
    Scott LJ; McCormack PL
    Drugs; 2008; 68(9):1239-72. PubMed ID: 18547134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and safety of olmesartan medoxomil in combination with either amlodipine or atenolol compared to respective monotherapies in healthy subjects.
    Bolbrinker J; Huber M; Scholze J; Kreutz R
    Fundam Clin Pharmacol; 2009 Dec; 23(6):767-74. PubMed ID: 19659504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
    Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
    Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olmesartan medoxomil.
    Warner GT; Jarvis B
    Drugs; 2002; 62(9):1345-53; discussion 1354-6. PubMed ID: 12076183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the pharmacokinetic characteristics of olmesartan medoxomil contribute to the improvement of blood pressure control?
    Wehling M
    Clin Ther; 2004; 26 Suppl A():A21-7. PubMed ID: 15291376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and safety of olmesartan medoxomil in combination with glibenclamide in healthy volunteers.
    Huber M; Bolbrinker J; Kreutz R
    Clin Exp Hypertens; 2006 Oct; 28(7):631-43. PubMed ID: 17060062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.